Regulatorische Updates
Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit
#pharmacy regulation ×
Regulatorische Updates
28. Sept. 2026•1 Min. Lesezeit
Seoul Pharmacists Association Calls for Safety‑First Rules on Telemedicine Drug Delivery and Standby Medicine Expansion
Ahead of a national audit, the Seoul City Pharmacists Association urged the National Assembly to prioritize patient safety and strengthen oversight before expanding telemedicine drug delivery and safety‑standby medicines.
Regulatorische Updates
24. Sept. 2026•1 Min. Lesezeit
Korean Pharmacist Society Mobilizes Against Expanded Telemedicine Prescription Delivery
The Korean pharmacist community is launching a full‑scale campaign against the government's plan to broaden delivery of prescription drugs for telemedicine, with the Korean Pharmaceutical Association forming an emergency task force.
Regulatorische Updates
23. Sept. 2026•1 Min. Lesezeit
Seongdong-gu Pharmaceutical Association Commits to Oppose Expansion of Drug Delivery and Convenience Store Sales
The Seongdong-gu Pharmaceutical Association resolved to actively oppose the expansion of drug delivery services and convenience‑store drug sales, sharing recent pharmacy complaint cases.
Regulatorische Updates
23. Sept. 2026•1 Min. Lesezeit
KPA Calls for Clear Licensing Rules for Pharmacists and Herbal Pharmacists in 358‑Day Relay Protest
The Korean Pharmaceutical Association held a relay protest at the Blue House, urging the government to clarify licensing scopes and set standards for herbal pharmacists' OTC sales and pharmacist employment.
Regulatorische Updates
22. Sept. 2026•1 Min. Lesezeit
Korean Parliament Begins Review of ‘Pharmacy External Capital Prevention Law’ to curb warehouse‑type pharmacies
Following earlier network‑pharmacy and name‑restriction laws, a new bill targeting external capital in pharmacies entered discussion, aiming to limit operators to one outlet and ban terms like “warehouse.”
Regulatorische Updates
22. Sept. 2026•1 Min. Lesezeit
대한약사회 30년 비상대책위원회 활동 검토: 성과와 한계
대한약사회는 지난 30년간 약사 직능 관련 주요 현안에 비상대책위원회를 꾸려 의약분업부터 원격 처방 약 배송까지 대응해 왔으며, 그 성과와 한계를 되짚는다.
Regulatorische Updates
22. Sept. 2026•1 Min. Lesezeit
Pharmacists Raise Concerns Over Expanded Prescription Home Delivery Policy in Gwangjin‑gu
The Gwangjin‑gu Pharmacists Association voiced worries to a lawmaker about the government's plan to broaden home delivery of prescription medicines, citing safety and regulatory issues.
Regulatorische Updates
21. Sept. 2026•1 Min. Lesezeit
Korean Pharmaceutical Association Forms Emergency Committee to Oppose Telemedicine Drug Delivery Expansion
The Korean Pharmaceutical Association has formed an emergency response committee and held a launch ceremony to block the government's plan to expand prescription drug delivery via telemedicine.
1
Regulatorische Updates
20. Sept. 2026•1 Min. Lesezeit
Korea clarifies that herbal pharmacists cannot dispense prescription drugs in their pharmacies
The Ministry of Health and Welfare confirmed that pharmacies run by hanyaksa are prohibited from preparing prescription medicines and selling OTC drugs.
Regulatorische Updates
20. Sept. 2026•1 Min. Lesezeit
Korean Pharmaceutical Association Escalates Measures Against Telemedicine Prescription Delivery
The Korean Pharmaceutical Association announced it will intensify its response to curb the expansion of prescription drug delivery via telemedicine and increase safety‑stock medicines, moving forward with its emergency committee.
Regulatorische Updates
18. Sept. 2026•1 Min. Lesezeit
Seongnam Pharmacists Association Holds 2026 Training Session
The Seongnam Pharmacists Association completed its 2026 training program at Seoul National University Hospital, covering six credits and addressing online drug delivery concerns.
Regulatorische Updates
17. Sept. 2026•1 Min. Lesezeit
Debate Shifts to Ownership of Warehouse‑Type Pharmacies in Korea
Korean authorities say legality of warehouse‑type pharmacies should be judged by funding sources and external influence, not just size, as corporate operators increasingly enter the market.